<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Cambridge Centre for Brain Repair</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/F40B6A38-1A7B-4153-A997-485BDCDF9E32"><gtr:id>F40B6A38-1A7B-4153-A997-485BDCDF9E32</gtr:id><gtr:firstName>Rodrigo</gtr:firstName><gtr:otherNames>Andres</gtr:otherNames><gtr:surname>Floto</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G108%2F485"><gtr:id>39E70011-5FB8-40AD-97E0-1720C870F763</gtr:id><gtr:title>The control of Fc-gamma receptor-mediated signalling and antigen presentation in immunity and autoimmunity.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G108/485</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2007-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2002-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>609618</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1572010</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Senior Research Fellowships in Clinical Science (Control of antigen processing by Fc receptors)</gtr:description><gtr:end>2013-07-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>0F749945-69A2-497F-9ADC-8F20DEF70373</gtr:id><gtr:outcomeId>nmN7WQKUJpY0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-08-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>B147EDD7-3A2C-462C-BE19-A68774F3575F</gtr:id><gtr:title>Small molecule enhancers of rapamycin-induced TOR inhibition promote autophagy, reduce toxicity in Huntington's disease models and enhance killing of mycobacteria by macrophages.</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/592ee7649769732bf204fc9e96a82554"><gtr:id>592ee7649769732bf204fc9e96a82554</gtr:id><gtr:otherNames>Floto RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>585d4e887a3b06.58555322</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0004A08-DAB4-47CF-8AA0-85D5DFA90DE5</gtr:id><gtr:title>Systemic lupus erythematosus-associated defects in the inhibitory receptor FcgammaRIIb reduce susceptibility to malaria.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4aa2cafd71498c626b9a9c9820a583e"><gtr:id>c4aa2cafd71498c626b9a9c9820a583e</gtr:id><gtr:otherNames>Clatworthy MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>0188762E551</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8237733A-EB1A-46D7-AB6B-05C4C08A3847</gtr:id><gtr:title>Novel targets for Huntington's disease in an mTOR-independent autophagy pathway.</gtr:title><gtr:parentPublicationTitle>Nature chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/66ef18d27aaab3e2eb29829908cf1ed4"><gtr:id>66ef18d27aaab3e2eb29829908cf1ed4</gtr:id><gtr:otherNames>Williams A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1552-4450</gtr:issn><gtr:outcomeId>7A20C51B11E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5FDDEB87-722E-455A-93F5-4F848CFF0E34</gtr:id><gtr:title>Dendritic cell stimulation by mycobacterial Hsp70 is mediated through CCR5.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/592ee7649769732bf204fc9e96a82554"><gtr:id>592ee7649769732bf204fc9e96a82554</gtr:id><gtr:otherNames>Floto RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>6472FA3B48C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06368AE9-C4AF-4689-8D28-53DF68C5EA44</gtr:id><gtr:title>Distinct cell-specific control of autoimmunity and infection by FcgammaRIIb.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a58b1ede4fbdc6a200401db143fe307"><gtr:id>2a58b1ede4fbdc6a200401db143fe307</gtr:id><gtr:otherNames>Brownlie RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>DDBB781F9C9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9DD3154-71F0-4CFB-B3ED-31E4CDA1CFD4</gtr:id><gtr:title>IFN-gamma- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0dc8267178fe5eccc89abeb20ec15544"><gtr:id>0dc8267178fe5eccc89abeb20ec15544</gtr:id><gtr:otherNames>Martineau AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>1D87756E2B3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1779498E-163F-4DB1-8CE6-90A0563FCFFD</gtr:id><gtr:title>The novel inhibitory receptor G6B is expressed on the surface of platelets and attenuates platelet function in vitro.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff9dab4a6ebb50cf7ea6861389d7404e"><gtr:id>ff9dab4a6ebb50cf7ea6861389d7404e</gtr:id><gtr:otherNames>Newland SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>FAE9E5888DB</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G108/485</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>